Pernille Auerbach

2.1k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

Pernille Auerbach is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Pernille Auerbach has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pharmacology. Recurrent topics in Pernille Auerbach's work include Diabetes Treatment and Management (8 papers), Adipose Tissue and Metabolism (6 papers) and Pharmacology and Obesity Treatment (5 papers). Pernille Auerbach is often cited by papers focused on Diabetes Treatment and Management (8 papers), Adipose Tissue and Metabolism (6 papers) and Pharmacology and Obesity Treatment (5 papers). Pernille Auerbach collaborates with scholars based in Denmark, United States and Spain. Pernille Auerbach's co-authors include Thorkil Ploug, Inge Gies, Claude Marcus, Margarita Barrientos‐Pérez, Silva Arslanian, Aaron S. Kelly, Paula M. Hale, Lucy D. Mastrandrea, Bente Stallknecht and Mads Rosenkilde and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Applied Physiology.

In The Last Decade

Pernille Auerbach

23 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

2020 431 citations Aaron S. Kelly, Pernille Auerbach et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pernille Auerbach Denmark	14	589	572	423	284	278	23	1.5k
J. Lundgren Denmark	16	596 1.0×	550 1.0×	327 0.8×	153 0.5×	366 1.3×	30	1.5k
Inge Gies Belgium	20	337 0.6×	602 1.1×	379 0.9×	361 1.3×	502 1.8×	70	1.7k
Breno Edson Sendão Alves Brazil	6	657 1.1×	1.1k 1.9×	751 1.8×	71 0.3×	346 1.2×	9	1.9k
Georgios K. Dimitriadis United Kingdom	22	364 0.6×	524 0.9×	113 0.3×	173 0.6×	323 1.2×	100	1.7k
Brandon M. Nathan United States	22	229 0.4×	860 1.5×	224 0.5×	268 0.9×	234 0.8×	61	1.9k
Ellen L. Connor United States	13	254 0.4×	419 0.7×	114 0.3×	521 1.8×	129 0.5×	20	1.5k
Marcello Lucchese Italy	20	200 0.3×	524 0.9×	243 0.6×	131 0.5×	114 0.4×	50	1.3k
Maria Guttadauria United States	15	587 1.0×	576 1.0×	942 2.2×	151 0.5×	153 0.6×	20	2.5k
Frédéric‐Simon Hould Canada	25	998 1.7×	448 0.8×	149 0.4×	175 0.6×	227 0.8×	60	2.6k
Ramin Alemzadeh United States	28	395 0.7×	1.0k 1.8×	72 0.2×	268 0.9×	219 0.8×	80	2.3k

Countries citing papers authored by Pernille Auerbach

Since Specialization

Citations

This map shows the geographic impact of Pernille Auerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pernille Auerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pernille Auerbach more than expected).

Fields of papers citing papers by Pernille Auerbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pernille Auerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pernille Auerbach. The network helps show where Pernille Auerbach may publish in the future.

Co-authorship network of co-authors of Pernille Auerbach

This figure shows the co-authorship network connecting the top 25 collaborators of Pernille Auerbach. A scholar is included among the top collaborators of Pernille Auerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pernille Auerbach. Pernille Auerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bradley, Ryan M., et al.. (2024). Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study. Diabetes Obesity and Metabolism. 26(10). 4674–4683. 4 indexed citations

Frías, Juan P., Pernille Auerbach, Harpreet S. Bajaj, et al.. (2021). Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial. The Lancet Diabetes & Endocrinology. 9(9). 563–574. 113 indexed citations

Tronieri, Jena Shaw, Anthony N. Fabricatore, Thomas A. Wadden, et al.. (2020). Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial. Obesity Facts. 13(6). 572–583. 9 indexed citations

Wadden, Thomas A., Jena Shaw Tronieri, Danny Sugimoto, et al.. (2020). Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial. Obesity. 28(3). 529–536. 142 indexed citations

Kelly, Aaron S., Pernille Auerbach, Margarita Barrientos‐Pérez, et al.. (2020). A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. New England Journal of Medicine. 382(22). 2117–2128. 431 indexed citations breakdown →

Auerbach, Pernille, et al.. (2020). A randomized, controlled trial of liraglutide for adolescents with obesity. Yearbook of pediatric endocrinology. 60 indexed citations

Ara, Ignacio, Pernille Auerbach, Steen Larsen, et al.. (2020). Low-Grade Inflammation Is Not Present in Former Obese Males but Adipose Tissue Macrophage Infiltration Persists. Biomedicines. 8(5). 123–123. 16 indexed citations

Blond, Martin Bæk, Theresia M. Schnurr, Mads Rosenkilde, et al.. (2019). PPARG Pro12Ala Ala carriers exhibit greater improvements in peripheral insulin sensitivity in response to 12 weeks of aerobic exercise training. Physiological Genomics. 51(6). 254–260. 4 indexed citations

Tronieri, Jena Shaw, Thomas A. Wadden, Michael Lund, et al.. (2019). SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations

10.

Tronieri, Jena Shaw, Thomas A. Wadden, Michael Lund, et al.. (2019). SAT-105 Weight Loss As Determined By Adherence To Reduced Caloric Diet, Increased Physical Activity, Liraglutide 3.0 Mg and Placebo: A Sub-analysis Of The SCALE IBT Trial. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations

11.

Caterson, Ian D., Assim A. Alfadda, Pernille Auerbach, et al.. (2019). Gaps to bridge: Misalignment between perception, reality and actions in obesity. Diabetes Obesity and Metabolism. 21(8). 1914–1924. 114 indexed citations

12.

Wadden, Thomas A., Jena Shaw Tronieri, Michael Lund, et al.. (2019). SAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations

13.

Sun, Kai, Jiyoung Park, Olga T. Gupta, et al.. (2014). Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nature Communications. 5(1). 3485–3485. 265 indexed citations

14.

Rosenkilde, Mads, Michala Holm Reichkendler, Pernille Auerbach, et al.. (2013). Effect of Different Doses of Exercise on Sleep Duration, Sleep Efficiency and Sleep Quality in Sedentary, Overweight Men. Research at the University of Copenhagen (University of Copenhagen). 3 indexed citations

15.

Christensen, Anders Nymark, Michala Holm Reichkendler, Rasmus Larsen, et al.. (2013). Calibrated image-derived input functions for the determination of the metabolic uptake rate of glucose with [18F]-FDG PET. Nuclear Medicine Communications. 35(4). 353–361. 7 indexed citations

16.

Rosenkilde, Mads, Michala Holm Reichkendler, Pernille Auerbach, et al.. (2013). Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial. Journal of Applied Physiology. 115(11). 1599–1609. 34 indexed citations

17.

Reichkendler, Michala Holm, Mads Rosenkilde, Pernille Auerbach, et al.. (2013). Only minor additional metabolic health benefits of high as opposed to moderate dose physical exercise in young, moderately overweight men. Obesity. 22(5). 1220–1232. 30 indexed citations

18.

Gram, Anne Sofie, Mads Rosenkilde, Michala Holm Reichkendler, et al.. (2013). Compliance with physical exercise: Using a multidisciplinary approach within a dose-dependent exercise study of moderately overweight men. Scandinavian Journal of Public Health. 42(1). 38–44. 9 indexed citations

19.

Reichkendler, Michala Holm, Pernille Auerbach, Mads Rosenkilde, et al.. (2013). Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging. American Journal of Physiology-Endocrinology and Metabolism. 305(4). E496–E506. 49 indexed citations

20.

Nordby, Pernille, Pernille Auerbach, Mads Rosenkilde, et al.. (2012). Endurance Training Per Se Increases Metabolic Health in Young, Moderately Overweight Men. Obesity. 20(11). 2202–2212. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact